Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: Results from South Australian clinical registry for advanced colorectal cancer

Clinical Colorectal Cancer

Volumn 11, Issue 4, 2012, Pages 247-254

  Khattak, Muhammad A ^a   Martin, Hilary L ^b   Beeke, Carol ^a   Price, Timothy ^c,d   Carruthers, Scott ^e   Kim, Susan ^f   Padbury, Robert ^a,f   Karapetis, Christos S ^a,f  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b Calvary Hospital   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

^f FLINDERS UNIVERSITY   (Australia)

Author keywords

Chemotherapy; Colorectal; Metastasis; Registry; Surgery; Survival

Indexed keywords

ARTICLE; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; HUMAN; INFORMATION PROCESSING; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL;

BONE NEOPLASMS; BRAIN NEOPLASMS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PELVIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 84868111722     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2012.06.004     Document Type: Article

References (34)

1. Cancer Council Australia Bowel cancer http://www.cancer.org.au/policy/ positionstatements/bowelcancer.htm Accessed: September 1, 2011
2. S.B. Edge, D.R. Byrd, C.C. Compton American Joint Committee on Cancer (AJCC) Cancer Staging Manual 7th ed. 2010 Springer New York
3. Surveillance epidemiology and end results (SEER) Program Cancer Statistics 2007 http://seer.cancer.gov/faststats/selections.php?#Output Accessed: June 27, 2012
4. Y. Fong, A.M. Cohen, J.G. Fortner Liver resection for colorectal metastases J Clin Oncol 15 1997 938 946
5. S.R. Alberts, W.L. Horvath, W.C. Sternfeld Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study J Clin Oncol 23 2005 9243 9249
6. N. Kemeny Management of liver metastases from colorectal cancer Oncology 20 2006 1161 1176 1179; discussion: 1179-80:1185-6
7. A. Muratore, D. Zorzi, H. Bouzari Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 14 2007 766 770
8. E. Van Cutsem, B. Nordlinger, R. Adam Towards a pan-European consensus on the treatment of patients with colorectal liver metastases Eur J Cancer 42 2006 2212 2221
9. N. Rotolo, L. De Monte, A. Imperatori Pulmonary resections of single metastases from colorectal cancer Surg Oncol 16 suppl 1 2007 S141 S144
10. A. Grothey, D. Sargent, R.M. Goldberg Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment J Clin Oncol 22 2004 1209 1214
11. C. Tournigand, T. André, E. Achille FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 2004 229 237
12. E.L. Neo, C. Beeke, T. Price South Australian clinical registry for metastatic colorectal cancer ANZ J Surg 81 2011 352 357
13. K. Jain, T. Price, C. Beeke An analysis of the effect of stage at diagnosis of bowel cancer on survival: findings from the South Australian clinical registry (SACR) for metastatic colorectal cancer (mCRC) J Clin Oncol 29 2011 abstr 3628
14. S. Rizzo, G. Bronte, D. Fanale Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Cancer Treat Rev 36 suppl 3 2010 S56 S61
15. J. Yu, R. Woods, C. Speers Prognostic factors (PF) influencing overall survival (OS) in stage IV colorectal cancer (CRC) J Clin Oncol 29 2011 abstr e14021
16. E.J. Morris, D. Forman, J.D. Thomas Surgical management and outcomes of colorectal cancer liver metastases Br J Surg 97 2010 1110 1118
17. M.C. de Jong, C. Pulitano, D. Ribero Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients Ann Surg 250 2009 440 448
18. M.K. McAfee, M.S. Allen, V.F. Trastek Colorectal lung metastases: results of surgical excision Ann Thorac Surg 53 1992 780 785 discussion: 785-6
19. Y. Saito, H. Omiya, K. Kohno Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment J Thorac Cardiovasc Surg 124 2002 1007 1013
20. C. Karapetis, A. Townsend, C. Beeke Impact of watching prior to commencement of chemotherapy for metastatic colorectal cancer (mCRC): findings from the South Australian clinical registry (SACR) for mCRC J Clin Oncol 29 2011 abstr e14139
21. Price T, Beeke C, Karapetis C, et al. Preliminary results from the South Australian (SA) clinical registry for advanced colorectal cancer (CRC): chemotherapy and surgical interventions, in Gastrointestinal cancers symposium. Abstract presented at GI cancer meeting, 2010.
22. J. Ovaska, H. Järvinen, H. Kujari Follow-up of patients operated on for colorectal carcinoma Am J Surg 159 1990 593 596
23. M.S. Rocklin, C.A. Slomski, A.L. Watne Postoperative surveillance of patients with carcinoma of the colon and rectum Am Surg 56 1990 22 27
24. V. Pugliese, H. Aste, S. Saccomanno Outcome of follow-up programs in patients previously resected for colorectal cancer Tumori 70 1984 203 208
25. D.J. Bruinvels, A.M. Stiggelbout, J. Kievit Follow-up of patients with colorectal cancer A meta-analysis Ann Surg 219 1994 174 182
26. A. Quentmeier, P. Schlag, M. Smok Re-operation for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival Eur J Surg Oncol 16 1990 319 325
27. R.M. Goldberg, T.R. Fleming, C.M. Tangen Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Ann Intern Med 129 1998 27 35
28. B.R. Lin, T.C. Chang, Y.C. Lee Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor Ann Surg Oncol 16 2009 1026 1032
29. J. Tie, L. Lipton, J. Desai KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer Clin Cancer Res 17 2011 1122 1130
30. K. Ohrling, D. Edler, M. Hallström Expression of thymidylate synthase in liver and lung metastases of colorectal cancer and their matched primary tumours Anticancer Res 28 2008 1741 1747
31. M. Jung, J.B. Ahn, J.H. Chang Brain metastases from colorectal carcinoma: prognostic factors and outcome J Neuroncol 101 2011 49 55
32. J.S. Barnholtz-Sloan, A.E. Sloan, F.G. Davis Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system J Clin Oncol 22 2004 2865 2872
33. P.H. Go, Z. Klaassen, M.C. Meadows Gastrointestinal cancer and brain metastasis: a rare and ominous sign Cancer 117 2011 3630 3640
34. M. Katoh, M. Unakami, M. Hara Bone metastasis from colorectal cancer in autopsy cases J Gastroenterol 30 1995 615 618